Chapel Hill, North Carolina Clinical Trials

A listing of Chapel Hill, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1028 clinical trials
featured
A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

www.MyelofibrosisResearch.com This is a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants with myelofibrosis.

Duke University Medical Center /ID# 214744
 (8.0 away) Contact site
  • 254 views
  • 29 Apr, 2021
  • +134 other locations
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.

hypertensive medication
antihypertensive therapy
antihypertensive drugs
renal angiogram
angiography
The University of North Carolina at Chapel Hill
 (1.6 away) Contact site
  • 877 views
  • 01 Aug, 2021
  • +82 other locations
featured
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma who have received at least 3 but not more than 5 prior lines of multiple myeloma therapy. …

daratumumab
refractory multiple myeloma
LINEBERGER COMPREHENSIVE CANCER CENTER AT UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
 (9.9 away) Contact site
  • 73 views
  • 28 May, 2020
  • +27 other locations
featured
A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

urinary tract cancer
Research Center
 (1.1 away) Contact site
  • 1062 views
  • 08 Dec, 2020
  • +61 other locations
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

RADIANCE-II is a pivotal trial, currently enrolling patients, to study the safety and effectiveness of the Paradise System to reduce blood pressure in patients with hypertension, in the absence of antihypertensive medications. RADIANCE-II is currently enrolling patients with uncontrolled blood pressure on 0-2 medications.  

The University of North Carolina at Chapel Hill
 (9.9 away) Contact site
  • 315 views
  • 30 Mar, 2021
  • +20 other locations
featured
Alpha-1 Study: A research study for individuals with Alpha-1 Antitrypsin Deficiency

The Alpha-1 Study is a clinical research study currently enrolling individuals 18 to 78 (inclusive) with Alpha-1 Antitrypsin Deficiency.   The purpose of this study is to evaluate the safety, tolerability, and effectiveness of an investigational medication in individuals with Alpha-1 Antitrypsin Deficiency. Interested individuals will be evaluated during a screening …

alpha 1-antitrypsin
deficiency
alpha1-proteinase inhibitor (human)
Alpha 1 Study Center
 (3.7 away) Contact site
  • 145 views
  • 23 Nov, 2020
  • +6 other locations
featured
[ONLINE] Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

This study is looking for people who have the APOE-e4 gene, which is associated with a higher risk for developing Alzheimer’s disease. The study is interested in learning about participants’ experiences. Contact Person Doris T. Zallen 540-231-4216dtzallen@vt.edu IMPORTANT: This communication is meant only to make you aware of an opportunity …

Online94
 (9.7 away) Contact site
  • 446 views
  • 17 Nov, 2020
  • +251 other locations
featured
[ONLINE] Dementia dogs: Their impact on community-dwelling persons with mild to moderate dementia

  This study is looking for pairs of participants: a person with mild-to-moderate dementia, and their caregiver. The study is interested in the difference that dogs can make in participants’ lives. Contact Person Frederic Dumont 1 418 529-9141 ext 6033frederic.dumont@cirris.ulaval.ca

moderate dementia
Online94
 (9.7 away) Contact site
  • 20 views
  • 12 Oct, 2020
  • +250 other locations
featured
[ONLINE] Daily Reflections of Dementia Caregivers

This study is looking for caregivers of family members who have mild cognitive impairment or dementia. This is a survey study that is interested in learning about caregivers’ experiences. Contact Person Dr. Carolyn Pickering 210-560-3075 pickeringc@uthscsa.edu Study Website:www.caregivingresearch.org/daily-reflections

Online94
 (9.7 away) Contact site
  • 84 views
  • 28 Jan, 2021
  • +252 other locations
featured
[ONLINE] Savonix Inc-Alzheimer’s Disease Discovery.

This study is looking for adults over the age of 22. This is an online cognitive study. Contact Person Reynald Hiole 415-919-7421 "mailto:rhiole@savonix.com"rhiole@savonix.com Click the link below to sign up https://www.assiststudy.org/

Online94
 (9.7 away) Contact site
  • 38 views
  • 28 Jan, 2021
  • +250 other locations